While Twist Bioscience Corp has underperformed by -1.40%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TWST rose by 108.59%, with highs and lows ranging from $43.21 to $11.46, whereas the simple moving average jumped by 28.98% in the last 200 days.
On January 17, 2024, Goldman Upgraded Twist Bioscience Corp (NASDAQ: TWST) to Buy. A report published by Berenberg on September 27, 2023, Initiated its previous ‘Buy’ rating for TWST. Scotiabank also rated TWST shares as ‘Sector Outperform’, setting a target price of $33 on the company’s shares in an initiating report dated January 05, 2023. Evercore ISI January 03, 2023d the rating to Outperform on January 03, 2023, and set its price target from $28 to $36. Cowen initiated its ‘Outperform’ rating for TWST, as published in its report on March 02, 2022. William Blair also rated the stock as ‘Outperform’.
Analysis of Twist Bioscience Corp (TWST)
Further, the quarter-over-quarter increase in sales is 31.81%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Twist Bioscience Corp’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -30.80% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.51, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 973.01K can be a very valuable indicator of volatility for TWST stock. On a monthly basis, the volatility of the stock is set at 5.77%, whereas on a weekly basis, it is put at 5.54%, with a loss of -0.18% over the past seven days. Furthermore, long-term investors anticipate a median target price of $40.75, showing growth from the present price of $33.75, which can serve as yet another indication of whether TWST is worth investing in or should be passed over.
How Do You Analyze Twist Bioscience Corp Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.36%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 109.15% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TWST shares are owned by institutional investors to the tune of 109.15% at present.
